SK, GSK partner to study adjuvanted Covid-19 vaccine candidate
The Phase 3 clinical trial will evaluate SK’s vaccine candidate GBP510 against the AstraZeneca/Oxford Covid-19 vaccine
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
01 Sep 21
The Phase 3 clinical trial will evaluate SK’s vaccine candidate GBP510 against the AstraZeneca/Oxford Covid-19 vaccine
27 Aug 21
A focus on how crucial mobile apps in clinical trials are in the wider landscape of emerging digital…
13 Aug 21
The majority of people vaccinated with Moderna’s vaccine maintained both binding and functional antibodies against SARS-CoV-2 variants
10 Aug 21
The Phase 3 trial evaluated the efficacy, safety and pharmacokinetics of Polivy in combination with R-CHP, compared to…
06 Aug 21
We focus on decentralisation and the challenges involved in operating clinical trials in a virtual setting.
05 Aug 21
The randomised, placebo-controlled, double-blind Phase 2b/3 ALLEGRO trial met the primary efficacy endpoint of improving scalp hair regrowth,…
30 Jul 21
We find out why sponsors and regulators are finally working to increase patient engagement across the life cycle…
23 Jul 21
We look at how, according to industry experts, professionals can look to guidance from the FDA to improve…
05 Jul 21
The data included new analysis from blood samples obtained from a subset of participants in the Phase 3…
21 Jun 21
Starpharma claims that its Viraleze is the only nasal spray to show more than 99.9% antiviral activity against…